{"id":"https://openalex.org/W2115196637","doi":"https://doi.org/10.1093/nass/nrn306","title":"Synthesis and antiviral activity of novel derivatives of 2'- -C-methylcytidine","display_name":"Synthesis and antiviral activity of novel derivatives of 2'- -C-methylcytidine","publication_year":2008,"publication_date":"2008-09-01","ids":{"openalex":"https://openalex.org/W2115196637","doi":"https://doi.org/10.1093/nass/nrn306","mag":"2115196637","pmid":"https://pubmed.ncbi.nlm.nih.gov/18776525"},"language":"en","primary_location":{"id":"doi:10.1093/nass/nrn306","doi":"https://doi.org/10.1093/nass/nrn306","is_oa":true,"landing_page_url":"https://doi.org/10.1093/nass/nrn306","pdf_url":"https://academic.oup.com/nass/article-pdf/52/1/605/3868537/nrn306.pdf","source":{"id":"https://openalex.org/S193378857","display_name":"Nucleic Acids Symposium Series","issn_l":"0261-3166","issn":["0261-3166","1746-8272"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nucleic Acids Symposium Series","raw_type":"journal-article"},"volume":null,"type":"conference-paper","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/nass/article-pdf/52/1/605/3868537/nrn306.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069006931","display_name":"Joanna Fogt","orcid":"https://orcid.org/0000-0002-9296-2164","observed_orcids":["https://orcid.org/0000-0002-9296-2164"]},"institutions":[{"id":"https://openalex.org/I4210152414","display_name":"Institute of Bioorganic Chemistry, Polish Academy of Sciences","ror":"https://ror.org/04ejdtr48","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210152414","https://openalex.org/I99542240"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"J. Fogt","raw_affiliation_strings":["Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland","institution_ids":["https://openalex.org/I4210152414"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111990209","display_name":"Piotr Januszczyk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]},{"id":"https://openalex.org/I4210146667","display_name":"Ajinomoto (Japan)","ror":"https://ror.org/044mkdq33","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210146667"]},{"id":"https://openalex.org/I4210152414","display_name":"Institute of Bioorganic Chemistry, Polish Academy of Sciences","ror":"https://ror.org/04ejdtr48","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210152414","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE","JP","PL"],"is_corresponding":false,"raw_author_name":"P. Januszczyk","raw_affiliation_strings":["Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland, 2 Aminoscience Laboratories, Ajinomoto Co. Inc., Kawasaki, Japan and 3 Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland, 2 Aminoscience Laboratories, Ajinomoto Co. Inc., Kawasaki, Japan and 3 Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I4210146667","https://openalex.org/I4210152414","https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090085321","display_name":"Grzegorz Framski","orcid":"https://orcid.org/0000-0002-1942-5565","observed_orcids":["https://orcid.org/0000-0002-1942-5565"]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]},{"id":"https://openalex.org/I4210146667","display_name":"Ajinomoto (Japan)","ror":"https://ror.org/044mkdq33","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210146667"]},{"id":"https://openalex.org/I4210152414","display_name":"Institute of Bioorganic Chemistry, Polish Academy of Sciences","ror":"https://ror.org/04ejdtr48","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210152414","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE","JP","PL"],"is_corresponding":false,"raw_author_name":"G. Framski","raw_affiliation_strings":["Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland, 2 Aminoscience Laboratories, Ajinomoto Co. Inc., Kawasaki, Japan and 3 Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland, 2 Aminoscience Laboratories, Ajinomoto Co. Inc., Kawasaki, Japan and 3 Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I4210146667","https://openalex.org/I4210152414","https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":null,"display_name":"T. Onishi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]},{"id":"https://openalex.org/I4210146667","display_name":"Ajinomoto (Japan)","ror":"https://ror.org/044mkdq33","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210146667"]},{"id":"https://openalex.org/I4210152414","display_name":"Institute of Bioorganic Chemistry, Polish Academy of Sciences","ror":"https://ror.org/04ejdtr48","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210152414","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE","JP","PL"],"is_corresponding":false,"raw_author_name":"T. Onishi","raw_affiliation_strings":["Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland, 2 Aminoscience Laboratories, Ajinomoto Co. Inc., Kawasaki, Japan and 3 Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland, 2 Aminoscience Laboratories, Ajinomoto Co. Inc., Kawasaki, Japan and 3 Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I4210146667","https://openalex.org/I4210152414","https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071597665","display_name":"Kunisuke Izawa","orcid":"https://orcid.org/0000-0002-7330-7084","observed_orcids":["https://orcid.org/0000-0002-7330-7084"]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]},{"id":"https://openalex.org/I4210146667","display_name":"Ajinomoto (Japan)","ror":"https://ror.org/044mkdq33","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210146667"]},{"id":"https://openalex.org/I4210152414","display_name":"Institute of Bioorganic Chemistry, Polish Academy of Sciences","ror":"https://ror.org/04ejdtr48","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210152414","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE","JP","PL"],"is_corresponding":false,"raw_author_name":"K. Izawa","raw_affiliation_strings":["Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland, 2 Aminoscience Laboratories, Ajinomoto Co. Inc., Kawasaki, Japan and 3 Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland, 2 Aminoscience Laboratories, Ajinomoto Co. Inc., Kawasaki, Japan and 3 Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I4210146667","https://openalex.org/I4210152414","https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040662398","display_name":"Erik De Clercq","orcid":"https://orcid.org/0000-0002-2985-8890","observed_orcids":["https://orcid.org/0000-0002-2985-8890"]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]},{"id":"https://openalex.org/I4210146667","display_name":"Ajinomoto (Japan)","ror":"https://ror.org/044mkdq33","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210146667"]},{"id":"https://openalex.org/I4210152414","display_name":"Institute of Bioorganic Chemistry, Polish Academy of Sciences","ror":"https://ror.org/04ejdtr48","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210152414","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE","JP","PL"],"is_corresponding":false,"raw_author_name":"E. De Clercq","raw_affiliation_strings":["Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland, 2 Aminoscience Laboratories, Ajinomoto Co. Inc., Kawasaki, Japan and 3 Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland, 2 Aminoscience Laboratories, Ajinomoto Co. Inc., Kawasaki, Japan and 3 Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I4210146667","https://openalex.org/I4210152414","https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089010495","display_name":"Johan H. Neyts","orcid":"https://orcid.org/0000-0002-0033-7514","observed_orcids":["https://orcid.org/0000-0002-0033-7514"]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]},{"id":"https://openalex.org/I4210146667","display_name":"Ajinomoto (Japan)","ror":"https://ror.org/044mkdq33","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210146667"]},{"id":"https://openalex.org/I4210152414","display_name":"Institute of Bioorganic Chemistry, Polish Academy of Sciences","ror":"https://ror.org/04ejdtr48","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210152414","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE","JP","PL"],"is_corresponding":false,"raw_author_name":"J. Neyts","raw_affiliation_strings":["Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland, 2 Aminoscience Laboratories, Ajinomoto Co. Inc., Kawasaki, Japan and 3 Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland, 2 Aminoscience Laboratories, Ajinomoto Co. Inc., Kawasaki, Japan and 3 Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I4210146667","https://openalex.org/I4210152414","https://openalex.org/I99464096"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070962562","display_name":"Jerzy Boryski","orcid":"https://orcid.org/0000-0001-7424-0953","observed_orcids":["https://orcid.org/0000-0001-7424-0953"]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]},{"id":"https://openalex.org/I4210146667","display_name":"Ajinomoto (Japan)","ror":"https://ror.org/044mkdq33","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210146667"]},{"id":"https://openalex.org/I4210152414","display_name":"Institute of Bioorganic Chemistry, Polish Academy of Sciences","ror":"https://ror.org/04ejdtr48","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210152414","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE","JP","PL"],"is_corresponding":true,"raw_author_name":"J. Boryski","raw_affiliation_strings":["Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland, 2 Aminoscience Laboratories, Ajinomoto Co. Inc., Kawasaki, Japan and 3 Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland, 2 Aminoscience Laboratories, Ajinomoto Co. Inc., Kawasaki, Japan and 3 Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I4210146667","https://openalex.org/I4210152414","https://openalex.org/I99464096"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5070962562"],"corresponding_institution_ids":["https://openalex.org/I24156275","https://openalex.org/I4210146667","https://openalex.org/I4210152414","https://openalex.org/I99464096"],"apc_list":null,"apc_paid":null,"fwci":10.7778,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.95862069,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"52","issue":"1","first_page":"605","last_page":"606"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.3215000033378601,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.3215000033378601,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.17900000512599945,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.16609999537467957,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nucleoside-analogs","display_name":"nucleoside analogues","score":0.8500000238418579},{"id":"https://openalex.org/keywords/antiviral-activity","display_name":"antiviral activity","score":0.8930000066757202},{"id":"https://openalex.org/keywords/hepatitis-c-virus","display_name":"hepatitis C virus","score":0.9769999980926514},{"id":"https://openalex.org/keywords/yellow-fever-virus","display_name":"yellow fever virus","score":0.9990000128746033},{"id":"https://openalex.org/keywords/flaviviridae","display_name":"Flaviviridae","score":0.9330000281333923},{"id":"https://openalex.org/keywords/viral-rna-replication-inhibition","display_name":"viral RNA replication inhibition","score":0.7059999704360962},{"id":"https://openalex.org/keywords/nucleoside-synthesis","display_name":"nucleoside synthesis","score":0.8389999866485596}],"concepts":[{"id":"https://openalex.org/C2779321679","wikidata":"https://www.wikidata.org/wiki/Q207722","display_name":"Pyrimidine","level":2,"score":0.6187529563903809},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5954362750053406},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5419301986694336},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5401450991630554},{"id":"https://openalex.org/C2777510210","wikidata":"https://www.wikidata.org/wiki/Q1331256","display_name":"Flaviviridae","level":4,"score":0.46926918625831604},{"id":"https://openalex.org/C140704245","wikidata":"https://www.wikidata.org/wiki/Q3933202","display_name":"Viral replication","level":3,"score":0.4675639569759369},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.4538766145706177},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.44550126791000366},{"id":"https://openalex.org/C2776543447","wikidata":"https://www.wikidata.org/wiki/Q28734","display_name":"Nucleoside","level":2,"score":0.4165351986885071},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.39932796359062195},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.282448947429657},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1890096366405487}],"mesh":[{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D003562","descriptor_name":"Cytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003562","descriptor_name":"Cytidine","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D003562","descriptor_name":"Cytidine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003562","descriptor_name":"Cytidine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D015005","descriptor_name":"Yellow fever virus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1093/nass/nrn306","doi":"https://doi.org/10.1093/nass/nrn306","is_oa":true,"landing_page_url":"https://doi.org/10.1093/nass/nrn306","pdf_url":"https://academic.oup.com/nass/article-pdf/52/1/605/3868537/nrn306.pdf","source":{"id":"https://openalex.org/S193378857","display_name":"Nucleic Acids Symposium Series","issn_l":"0261-3166","issn":["0261-3166","1746-8272"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nucleic Acids Symposium Series","raw_type":"journal-article"},{"id":"pmid:18776525","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18776525","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nucleic acids symposium series (2004)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1093/nass/nrn306","doi":"https://doi.org/10.1093/nass/nrn306","is_oa":true,"landing_page_url":"https://doi.org/10.1093/nass/nrn306","pdf_url":"https://academic.oup.com/nass/article-pdf/52/1/605/3868537/nrn306.pdf","source":{"id":"https://openalex.org/S193378857","display_name":"Nucleic Acids Symposium Series","issn_l":"0261-3166","issn":["0261-3166","1746-8272"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nucleic Acids Symposium Series","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2115196637.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2128018863","https://openalex.org/W2950742949","https://openalex.org/W1964616708","https://openalex.org/W1982708109","https://openalex.org/W2026122224","https://openalex.org/W2154812981","https://openalex.org/W2324915322","https://openalex.org/W2026101877","https://openalex.org/W2029154885","https://openalex.org/W2079199249"],"abstract_inverted_index":{"A":[0],"series":[1],"of":[2,5,14,34],"novel":[3],"derivatives":[4],"2'-C-beta-methylcytidine,":[6],"involving":[7],"nucleosides":[8],"modified":[9],"in":[10,31],"the":[11,15,35,40],"\"upper":[12],"part\"":[13],"pyrimidine":[16],"base":[17],"(N(4)-":[18],"and/or":[19],"5-position),":[20],"has":[21],"been":[22],"synthesized":[23],"and":[24,39],"evaluated":[25],"for":[26],"their":[27],"inhibitory":[28],"effect":[29],"on":[30],"vitro":[32],"replication":[33],"hepatitis":[36],"C":[37],"virus":[38,43],"yellow":[41],"fever":[42],"(both":[44],"Flaviviridae).":[45]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}